BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9683266)

  • 1. Physical association between CD155 and CD44 in human monocytes.
    Freistadt MS; Eberle KE
    Mol Immunol; 1997 Dec; 34(18):1247-57. PubMed ID: 9683266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?
    Maherally Z; Smith JR; An Q; Pilkington GJ
    PLoS One; 2012; 7(2):e30691. PubMed ID: 22363471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
    Freistadt MS; Eberle KE
    Microb Pathog; 2000 Oct; 29(4):203-12. PubMed ID: 10993739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin.
    Lange R; Peng X; Wimmer E; Lipp M; Bernhardt G
    Virology; 2001 Jul; 285(2):218-27. PubMed ID: 11437656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens.
    Maier MK; Seth S; Czeloth N; Qiu Q; Ravens I; Kremmer E; Ebel M; Müller W; Pabst O; Förster R; Bernhardt G
    Eur J Immunol; 2007 Aug; 37(8):2214-25. PubMed ID: 17621371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 is not required for poliovirus replication.
    Bouchard MJ; Racaniello VR
    J Virol; 1997 Apr; 71(4):2793-8. PubMed ID: 9060634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection.
    Iwasaki A; Welker R; Mueller S; Linehan M; Nomoto A; Wimmer E
    J Infect Dis; 2002 Sep; 186(5):585-92. PubMed ID: 12195344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of poliovirus serotypes with their common cellular receptor, CD155.
    He Y; Mueller S; Chipman PR; Bator CM; Peng X; Bowman VD; Mukhopadhyay S; Wimmer E; Kuhn RJ; Rossmann MG
    J Virol; 2003 Apr; 77(8):4827-35. PubMed ID: 12663789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4.
    del Fresno C; Otero K; Gómez-García L; González-León MC; Soler-Ranger L; Fuentes-Prior P; Escoll P; Baos R; Caveda L; García F; Arnalich F; López-Collazo E
    J Immunol; 2005 Mar; 174(5):3032-40. PubMed ID: 15728517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155.
    Ravens I; Seth S; Förster R; Bernhardt G
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1364-71. PubMed ID: 14652024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the poliovirus receptor with poliovirus.
    He Y; Bowman VD; Mueller S; Bator CM; Bella J; Peng X; Baker TS; Wimmer E; Kuhn RJ; Rossmann MG
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):79-84. PubMed ID: 10618374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
    Chandramohan V; Bryant JD; Piao H; Keir ST; Lipp ES; Lefaivre M; Perkinson K; Bigner DD; Gromeier M; McLendon RE
    Arch Pathol Lab Med; 2017 Dec; 141(12):1697-1704. PubMed ID: 28829151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains.
    Meyer D; Seth S; Albrecht J; Maier MK; du Pasquier L; Ravens I; Dreyer L; Burger R; Gramatzki M; Schwinzer R; Kremmer E; Foerster R; Bernhardt G
    J Biol Chem; 2009 Jan; 284(4):2235-44. PubMed ID: 19056733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
    Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
    Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique CD44 monoclonal antibody identifies a new T cell activation pathway.
    Pierres A; Lipcey C; Mawas C; Olive D
    Eur J Immunol; 1992 Feb; 22(2):413-7. PubMed ID: 1347013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
    Levesque MC; Haynes BF
    J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
    Denning SM; Le PT; Singer KH; Haynes BF
    J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.
    Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNAM-1 and PVR regulate monocyte migration through endothelial junctions.
    Reymond N; Imbert AM; Devilard E; Fabre S; Chabannon C; Xerri L; Farnarier C; Cantoni C; Bottino C; Moretta A; Dubreuil P; Lopez M
    J Exp Med; 2004 May; 199(10):1331-41. PubMed ID: 15136589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.